| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.084 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |